BNP Paribas Financial Markets’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.3K Buy
6,149
+119
+2% +$239 ﹤0.01% 5249
2025
Q4
$15.7K Buy
6,030
+816
+16% +$2.23K ﹤0.01% 5076
2025
Q3
$15.6K Buy
5,214
+2,495
+92% +$8.91K ﹤0.01% 4943
2025
Q2
$10.9K Sell
2,719
-44,278
-94% -$163K ﹤0.01% 4822
2025
Q1
$157K Buy
46,997
+5,821
+14% +$27.8K ﹤0.01% 3843
2024
Q4
$254K Buy
+41,176
New +$239K ﹤0.01% 3728

Other funds holding BTMD

BNP Paribas Financial Markets's BTMD Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its Biote Corp (BTMD) stake by 2% in Q1 2026, buying an estimated $239 and bringing the position to 6,149 shares worth $8.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5249.

BNP Paribas Financial Markets first reported a position in BTMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $254K in Q4 2024. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • BNP Paribas Financial Markets held 6,149 shares of Biote Corp worth $8.3K as of Q1 2026.
  • BNP Paribas Financial Markets bought 119 Biote Corp shares in Q1 2026, an estimated $239.
  • Biote Corp made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5249 holding.
  • BNP Paribas Financial Markets first reported a position in Biote Corp in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Biote Corp position peaked at $254K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.